Microfluidic eDAR System for CTC Isolation and Analysis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for isolating and analyzing circulating tumor cells (CTCs) from fluid samples are inefficient and often result in low recovery rates and high false positive rates, making it difficult to provide accurate prognostic information for cancer patients.

Innovation Solution

The development of a microfluidic chip-based system, Ensemble Decision Aliquot Ranking (eDAR), which uses hydrodynamic switching and immunostaining/photobleaching techniques to efficiently isolate and analyze CTCs, achieving high recovery rates and low false positive rates by sorting cells based on specific biomarker profiles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current methods are used for isolating and analyzing CTCs, then the process is simpler, but the recovery rate is low and false positive rate is high

Engineering Contradiction:
Improverecovery rate and false positive rateVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system segments the fluid sample into discrete aliquots and processes them individually through the microfluidic chip. Each aliquot is analyzed separately, enabling precise control over the isolation and detection process, which improves recovery rates while maintaining manageable system complexity through modular processing

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system performs preliminary immunostaining of CTCs with fluorescently labeled antibodies before the main detection process. This pre-labeling step ensures that target cells are properly marked for subsequent detection, improving reliability by reducing false negatives while the automated flow control manages overall process complexity

Inventive Principle:
Principle #10Preliminary action

2Productivity

If hydrodynamic switching and immunostaining techniques are used, then isolation efficiency improves, but device complexity increases

Engineering Contradiction:
Improveisolation efficiencyVSAvoidmicrofluidic system complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The system employs hydrodynamic switching using controlled fluid flow through the microfluidic chip to direct and isolate CTCs. By manipulating pressure gradients and flow rates, the system achieves efficient cell separation and concentration without requiring complex mechanical moving parts, thus improving productivity while keeping the device relatively simple

Inventive Principle:
Principle #29Pneumatics and hydraulics

Solution Approach 2:

The microfluidic chip is designed to perform multiple functions within a single integrated device: immunostaining, hydrodynamic switching, cell isolation, and detection. This multi-functionality improves overall isolation efficiency by consolidating steps that would otherwise require separate devices, while the integrated design actually reduces overall system complexity compared to multiple separate components

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The eDAR system enables the efficient isolation of CTCs with greater than 95% recovery rate and less than 5% false positive rate, allowing for accurate analysis and prognosis in cancer management.

Implementation Method 1

detecting a signal from a first tag using a source of radiation

Methodology Applied
Scientific EffectRadiation detection: Photoelectric Effect

Implementation Method 2

reducing the intensity of the signal of the first tag

Methodology Applied
Scientific EffectPhotobleaching: Photo-oxidation

Data Source

PatentUS11808767B2Methods, compositions and systems for microfluidic assays
Publication Date: 2023.11.07 UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION
  • US11808767B2 patent drawing
  • US11808767B2 patent drawing
  • US11808767B2 patent drawing

AI summary

Provided herein, among other aspects, are methods and apparatuses for analyzing particles in a sample. In some aspects, the particles can be analytes, cells, nucleic acids, or proteins and contacted with a tag, partitioned into aliquots, detected by a ranking device, and isolated. The methods and apparatuses provided herein may include a microfluidic chip. In some aspects, the methods and apparatuses may be used to quantify rare particles in a sample, such as cancer cells and other rare cells for disease diagnosis, prognosis, or treatment.